In this dataset, RNA sequencing (RNA-seq) analysis was performed on 13 treatment-naive HER2 + breast tumors and 7 distant metastases of HER2 + tumors relapsed posttrastuzumab treatment (Additional file 1: Fig. S6A). This evidence concerns the gene ERBB2 and breast neoplasm.